🇺🇸

Bristol-Myers Squibb makes $12 million investment in Compugen, sets up research partnership

Credit: Proactive Investors- Published 6 days ago
US pharmaceutical giant Bristol-Myers Squibb (NYSE:BMY) has agreed to make a $12 million investment in Compugen Ltd (NASDAQ:CGEN), the Israeli drug developer, as part of a new partnership between the companies, which also involves shared cancer trials. The new trials will evaluate the safety and tolerability of Compugen’s...
Advertisement

Recent related videos from verified sources

Researchers Awarded $1 Million Prize At Magee-Womens Research Summit 00:41
Credit: KDKA CBS 2 Pittsburgh - Published 1 week ago 


Over 1 million People Without Power After Hurricane Michael 00:32
Credit: Wochit News - Published 5 days ago 


Recent related news from verified sources

Alkane Resources Ltd (ASX:ALK) has completed an investment into gold exploration company Calidus Resources Ltd (ASX:CAI) for 125 million ordinary shares at a...
15 hours ago • Proactive Investors

Saratoga Investment Corp (NYSE:SAR), the New York-based specialty finance company, fell short of Wall Street’s earnings estimate for its fiscal second quarter,...
1 week ago • Proactive Investors

The Charles Schwab Corporation (NYSE:SCHW), one of the biggest banks and brokerage groups in the US, reported standout results on Monday, mainly as a result of...
2 days ago • Proactive Investors

MMJ PhytoTech Ltd (ASX:MMJ) has an active strategy in the medicinal cannabis sector which chief executive officer Jason Conroy will outline at the Proactive CEO...
6 days ago • Proactive Investors

You might like